Search

everythinglearnresearchcommunity

for

Search:↓

Accurate prediction of eye, hair, and skin color in Latin American populations requires region-specific models and ethical guidelines.

The green alga Parachlorella sp. has potential for use in cosmetics and health products due to its antioxidant, anti-hypertensive, and hair growth properties.

Cholesterol helps hair grow by activating nerves and boosting hair follicle stem cells.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Platycladus orientalis flavonoids protect balding hair from UV damage and slow hair color change.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

A unique skin cell similar to hair bulb melanocytes was identified, with better preservation using permanganate fixation.

Certain chemicals cause hair graying in black mice but not yellow mice.

Hairless dogs can be used to study human hypertrophic scars.

PMEE may help reverse greying hair by boosting melanin production.

Dendritic cells help regulate skin development and hair growth in mice.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Dystonia may be part of PAS-4 and linked to immune issues.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Dextroamphetamine may help treat alopecia areata.

Myotonic dystrophy may be classified as a segmental progeroid disorder.

Neuromyotonia and morphoea can occur together in the same body areas.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.